XML 54 R39.htm IDEA: XBRL DOCUMENT v3.8.0.1
Stock-Based Compensation (Tables)
12 Months Ended
Dec. 31, 2017
Disclosure of Compensation Related Costs, Share-based Payments [Abstract]  
Schedule of Stock-Based Compensation Expense Recognized
Stock-based compensation expense recognized in the consolidated statements of operations is summarized below:
 
Year Ended
December 31,
(in thousands)
2017
 
2016
 
2015
Cost of goods sold
$
1,692

 
$
359

 
$
192

Sales and marketing
640

 
339

 
254

General and administrative
2,964

 
1,438

 
1,330

Research and development
632

 
388

 
226

Total stock-based compensation expense
$
5,928

 
$
2,524

 
$
2,002

Schedule of Assumptions used in Valuing Stock Options Granted
The table below summarizes the key assumptions used in valuing stock options granted:
 
 
Year Ended
December 31, 2015
Expected volatility
 
26.0% - 30.0%
Expected dividends
 
Expected life (in years)
 
4.1 - 6.3
Risk-free interest rate
 
1.3% - 1.9%
Summary of Option Activity
A summary of option activity for 2017 is presented below:
 
Time
Based
 
Performance
Based
 
Total
Stock
Options
 
Weighted-
Average
Exercise
Price
 
Weighted-
Average
Remaining
Contractual
Term
(Years)
 
Aggregate
Intrinsic
Value
Balance at January 1, 2017
818,331

 
219,006

 
1,037,337

 
$
10.63

 
 
 
 
Options granted

 

 

 
$

 
 
 
 
Options exercised
(338,133
)
 
(127,099
)
 
(465,232
)
 
$
6.98

 
 
 
 
Options forfeited and expired
(2,565
)
 
(4,115
)
 
(6,680
)
 
$
9.47

 
 
 
 
Outstanding at December 31, 2017
477,633

 
87,792

 
565,425

 
$
13.65

 
3.9
 
$
4,150,751

Vested and expected to vest at December 31, 2017
477,633

 
87,792

 
565,425

 
$
13.65

 
3.9
 
$
4,150,751

Exercisable at December 31, 2017
371,861

 
87,792

 
459,653

 
$
14.94

 
4.4
 
$
2,774,300

Summary of Restricted Stock Awards Activity
A summary of performance restricted stock award activity for 2017 is presented below:
 
Shares
 
Weighted-
Average Grant
Date Fair Value Per Share
Nonvested performance restricted stock, January 1, 2017

 
$

Granted
303,495

 
$
16.69

Vested

 
$

Cancelled
(12,323
)
 
$
16.62

Nonvested performance restricted stock, December 31, 2017
291,172

 
$
16.70

A summary of restricted stock awards activity for 2017 is presented below:
 
Shares
 
Weighted-
Average Grant
Date Fair Value Per Share
Nonvested restricted stock, January 1, 2017
2,156,372

 
$
3.71

Granted
395,146

 
$
12.94

Vested
(744,244
)
 
$
3.86

Cancelled
(42,012
)
 
$
3.78

Nonvested restricted stock, December 31, 2017
1,765,262

 
$
5.72